Erick Lucera

Chief Financial Officer, Dyne Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.2M

Companies

Latest trade

Aug 13, 2026

Companies

Dyne Therapeutics, Inc.Chief Financial Officer −$0.2M

Trades

DYN Sold 1,797 shares at $26.28 · planned $0.0M Aug 13

DYN Sold 2,362 shares at $20.37 $0.0M Jun 25

DYN Sold 1,448 shares at $18.36 · planned $0.0M May 13

DYN Sold 5,727 shares at $18.64 · planned $0.1M Apr 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.